An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Clinical trial NCT05663853 · COMPLETED

Trial details

NCT number: NCT05663853
Sponsor: LAPIX Therapeutics Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive

Start date: 2023-03-28
Primary completion: 2024-04-30
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.